• 10 mM dNTP Mixture: Precision for Next-Gen DNA Synthesis

  2026-07-22

  Explore the scientific nuances and advanced applications of the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) mixture. This in-depth analysis highlights its unique role as a DNA synthesis reagent and integrates new insights into nucleic acid delivery efficiency.

• ACE2 Activation by Diminazene Aceturate Mitigates Sepsis Car

  2026-07-22

  The referenced study demonstrates that pharmacological activation of ACE2 with Diminazene Aceturate (DIZE) protects against sepsis-induced cardiomyopathy in mice by promoting MasR-Sirt1-mediated mitochondrial biogenesis. These findings clarify a mechanistic link between ACE2 signaling and cardiac protection during sepsis, suggesting new research directions in mitochondrial dysfunction.

• Intestinal TM6SF2 Deficiency Drives Steatohepatitis via LPA

  2026-07-21

  The referenced Nature Metabolism study uncovers how intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by preserving gut barrier integrity and regulating host–microbe interactions. Mechanistically, TM6SF2 deficiency in the gut promotes lysophosphatidic acid (LPA) signaling, linking intestinal lipid handling with hepatic inflammation and establishing new therapeutic entry points for MASH.

• ACE2 Activation via Diminazene Aceturate Counters Sepsis Car

  2026-07-21

  This study demonstrates that pharmacological activation of ACE2 with Diminazene Aceturate protects against sepsis-induced cardiomyopathy in mice by promoting mitochondrial biogenesis through the MasR-Sirt1 axis. The findings clarify a mechanistic pathway linking ACE2 signaling to cardiac protection in sepsis, informing targeted research approaches in mitochondrial dysfunction and infection models.

• Prostaglandin E2: Guiding Translational Inflammation Researc

  2026-07-20

  This thought-leadership article equips translational researchers with mechanistic insights and strategic guidance for leveraging Prostaglandin E2 (PGE2) in inflammation research and beyond. Integrating evidence from recent advances in intervertebral disc degeneration (IVDD) therapeutics, the piece highlights how APExBIO’s PGE2 empowers reproducible, high-impact workflows and bridges emerging clinical applications. Key competitive and translational considerations are addressed, with a forward-looking outlook grounded in cited literature.

• VX-661 and Proteostasis: Precision Tools for CFTR Variant Re

  2026-07-20

  Explore how VX-661, an advanced F508del CFTR corrector, leverages proteostatic modulation for targeted cystic fibrosis research. Discover unique assay strategies and implications from the latest calnexin-dependent rescue insights.

• Resazurin Cell Viability Assay Kit: Precision in High-Throug

  2026-07-19

  The Resazurin Cell Viability Assay Kit empowers researchers with ultra-sensitive, non-toxic quantification of live cells, uniquely supporting both fluorescence and colorimetric detection for unparalleled flexibility. Its ready-to-use format and broad compatibility with animal, plant, and microbial systems set a new benchmark for streamlined, high-throughput proliferation and apoptosis assays.

• Cisplatin (CDDP): Apoptosis, Chemosensitivity, and Next-Gen

  2026-07-18

  Explore the multifaceted roles of Cisplatin (CDDP) in apoptosis induction, chemosensitivity modulation, and advanced cancer model development. This article provides a scientific deep dive into mechanistic insights and practical strategies for leveraging Cisplatin in cutting-edge cancer research.

• Diminazene Aceturate: Mechanistic Insights for Parasite and

  2026-07-17

  Explore the multifaceted uses of Diminazene Aceturate in advanced trypanosome and mitochondrial biogenesis research. This article delivers a unique mechanistic analysis, bridging molecular action with practical protocol optimization and the latest discoveries in ACE2 activation.

• Metformin Hydrochloride in HO Research: Protocols & Innovati

  2026-07-17

  Metformin Hydrochloride (Metformin HCl) stands out for its dual utility as a metabolic modulator and a unique inhibitor of pathological ossification. This article details actionable workflows, advanced applications, and troubleshooting strategies to maximize reproducibility in musculoskeletal and metabolic research.

• MEG3 Modulates NiO Nanoparticle-Induced Pulmonary Fibrosis v

  2026-07-16

  This study uncovers how the long noncoding RNA MEG3 regulates TGF-β1-mediated PI3K/AKT pathway activation in response to nickel oxide nanoparticle exposure, leading to pulmonary fibrosis. The work provides mechanistic insight into fibrogenesis, highlighting the therapeutic relevance of targeting the PI3K/AKT axis in nanoparticle-induced lung injury.

• Microbiota–Tryptophan–AhR Axis Regulates Intestinal Repair i

  2026-07-16

  Li et al. demonstrate that Huangqin decoction (HQD) restores mucosal integrity in ulcerative colitis by modulating gut microbiota, enhancing microbial tryptophan metabolite production, and activating the aryl hydrocarbon receptor (AhR), which promotes intestinal stem cell differentiation. Their work establishes a mechanistic link between microbial metabolism, AhR signaling, and epithelial regeneration, with broad implications for environmental toxicology and regenerative medicine.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Insights and

  2026-07-15

  The referenced review details the use of CXCR4-targeted ligands for both diagnostic imaging and precision therapy in lymphoma, focusing on how receptor overexpression drives malignancy and therapy resistance. It highlights novel radiotracers and antagonists, discusses their integration into theranostic strategies, and considers practical challenges and future prospects for translational oncology research.

• AO/PI Staining Solution: Elevating Cell Viability Assays in

  2026-07-15

  Explore how AO/PI Staining Solution advances fluorescent DNA dye-based cell viability assays, enabling precise live/dead discrimination and accurate cell counting. This article uniquely connects robust viability analysis to cutting-edge inflammation and apoptosis research, offering practical insights beyond standard protocols.

• BHPF as a GPER Inhibitor: Mechanisms in Neuroblastoma Apopto

  2026-07-14

  This study identifies fluorene-9-bisphenol (BHPF) as a direct inhibitor of the G protein-coupled estrogen receptor 1 (GPER), revealing its molecular recognition and antagonistic mechanisms in human neuroblastoma cells. These findings clarify how BHPF disrupts estrogenic signaling and highlight the importance of receptor-selective tools for mechanistic research.

16801 records 1/1121 page Next 12345 下5页 Last page